Drug Intended for the Treatment of Raynaud's Phenomena, Secondary to Systemic Sclerosis SAN DIEGO, April 13, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today its filing with the U.S. Food & Drug Administration ("FDA") requesting orphan drug designation for RayVa™, the Company's drug candidate indicated for the treatment of Raynaud's
We’ve heard from a manufacturer who has been developing a heated steering wheel cover and it’s great news: The prototype is ready and it’s “everything we wanted it to be!” We’ll be seeing the prototype later this month, and if all goes well, the product may be available for purchase in time for next fall. In
How did you celebrate???
The Hackensack NJ Support Group of the Tri-State Scleroderma Foundation is sponsoring an Autoimmune Disease Patient Education Panel
Good news for fellow Frosties with Lupus! HEALTH INDUSTRY MARCH 9, 2011, 6:22 P.M. ET Wall Street Journal The Food and Drug Administration approved a new lupus drug from Human Genome Sciences Inc. and GlaxoSmithKline PLC, marking the first new treatment for the autoimmune disease in more than 50 years.